Back to Rankings

DNTH

Dianthus TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
DNTH vs peer average
60/100
DNTH vs. peer average (B vs. C)
Grade spread
A 2 · B 3 · C 1 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AGIO is the first available peer comparator.

Another rare-disease biotech comparator for cash-backed development-stage valuation and pipeline concentration risk, but only a loose operating peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAGIOAgios
DNTH
Dianthus Therapeutics
AGIO
Agios
Grade
B
F
Momentum
92
35
Value
41
41
Sentiment
50
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs AGIO

DNTH / AGIO
Grade Position
In line
DNTH vs. peer average (B vs. C)
60/100
Momentum
92
DNTH
Value
41
DNTH
Sentiment
50
DNTH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs DNTH
1
AGIO
AGIO
F
20/100
+3
2
BCRX
BCRX
B
80/100
Even
3
CELC
Celcuity Inc Common
A
100/100
-1
4
TWST
Twist Bioscience Corp Common
C
60/100
+1
5
NNNN
Anbio Biotechnology Class A Common
N/A
-
-
AGIO is the first peer returned for this comparison set.